Medtronic's next-generation DES matches Abbott's Xience V in real-world study
This article was originally published in Clinica
Executive Summary
Medtronic's Resolute drug-eluting stent (DES) is as good as its market-leading rival, Abbott's Xience V, according to the first major head-to-head study of the two devices.